Melanoma shows improved regression with combination of PV-10 and checkpoint inhibitor
11/18/2014
In a mouse model, PV-10 used alongside immune check point inhibitors improved melanoma regression and increased T cell activity, according to research presented at SITC's meeting.
New strategy to reduce cancer impact, Australia
11/18/2014
Cancer Australia has released its new Strategic Plan 2014-19, which articulates the importance of a strategic, nationally coordinated and evidence-based approach to address the current and future...
Novocure™, a commercial stage oncology company, announced today that Tumor Treating Fields (TTFields) delivered by the NovoTTF™-100A System in combination with standard-of-care...
The secret life of anti-cancer drugs
11/18/2014
The public is bombarded with news of exciting developments in cancer research every day, with new anti-cancer drugs greeted with excitement. But what happens to these drugs?
Breast cancer; pooled analysis results of two Phase III Halaven® (eribulin) trials
11/18/2014
The results from a pooled analysis of two Phase III Halaven(R) (eribulin) trials are published in Breast Cancer Research and Treatment.
In prostate cancer patients carrying 'BRCA' mutations, conventional therapies are less efficient
11/18/2014
Prostate cancer patients carrying inherited mutations in the BRCA genes respond less well to conventional treatment, including surgery and/or radiotherapy - and they also have a lower survival rate...
Among other health benefits walnuts slow prostate cancer growth
11/18/2014
Researchers at UC Davis and other institutions have found that diets rich in whole walnuts or walnut oil slowed prostate cancer growth in mice.
Receptors for targeted cancer therapy identified by new imaging technique
11/18/2014
Dartmouth researchers have developed a fluorescence imaging technique that can more accurately identify receptors for targeted cancer therapies without a tissue biopsy.
Pinpointing aggressiveness of breast cancer tumours using cutting-edge computer software
11/18/2014
Researchers at Western University are using cutting-edge genetic mutation-analysis software developed in their lab to interpret mutations in tumour genome that may provide insight into determining...
Scientists find way to reduce ovarian cancer tumours, chemo doses
11/18/2014
In a potential breakthrough against ovarian cancer, University of Guelph researchers have discovered how to both shrink tumours and improve drug delivery, allowing for lower doses of chemotherapy and...